Loading clinical trials...
Loading clinical trials...
Etude Resume (Retraitement Sunitinib Rein Metastatique)
Conditions
Interventions
sunitinib: observational study
Locations
18
France
CHU de la Timone
Marseille, Cedex 5, France
Hopital albert Michalon
Grenoble, Cedex 9, France
Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire
Saint-Priest-en-Jarez, France, France
Centre Paul Papin
Angers, France
Hôpital Saint-André
Bordeaux, France
Centre Catalan Urologie Andrologie
Cabestany, France
Start Date
July 1, 2013
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
April 30, 2015
NCT06391099
NCT07227415
NCT06835972
NCT07175480
NCT05700461
NCT05122546
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions